{"id":786,"date":"2024-11-25T23:48:20","date_gmt":"2024-11-25T23:48:20","guid":{"rendered":"http:\/\/cetaitdemain.org\/?p=786"},"modified":"2024-11-25T23:48:20","modified_gmt":"2024-11-25T23:48:20","slug":"the-choice-of-the-reference-cutoff-appears-fundamental-to-discriminate-patients-hypothetically-protected-by-adequate-levels-of-putatively-neutralising-antibodies","status":"publish","type":"post","link":"https:\/\/cetaitdemain.org\/?p=786","title":{"rendered":"\ufeffThe choice of the reference cut\\off appears fundamental to discriminate patients hypothetically protected by adequate levels of putatively neutralising antibodies"},"content":{"rendered":"<p>\ufeffThe choice of the reference cut\\off appears fundamental to discriminate patients hypothetically protected by adequate levels of putatively neutralising antibodies. An asymptomatic SARS\\CoV\\2 infection was documented in two patients belonging to the third and seventh cohort when nasopharyngeal swabs were taken as surveillance before their hospital access on 9 July 2021. track the putatively neutralising antibodies titres. To address some of these questions, we prospectively analysed the anti\\SARS\\CoV\\2 spike SC-144 (S) protein immunoglobulin G (IgG) titres over multiple time\\points SC-144 (TPs), and monitored clinical outcomes [asymptomatic infections and coronavirus disease 2019 (COVID\\19)], after two doses of 30?g 3?weeks apart of BNT162b2 in 182 consecutive patients with different malignancies [chronic myeloid leukaemia (CML), (%) [(%) <a href=\"https:\/\/www.adooq.com\/sc-144.html\">SC-144<\/a> [TP2)28 (8)20 (0)32 (0)32 (0)19 (0)10 (0)17 (1)50 (1)** GMC (95% CI), au\/ml [(%) [(%) [(%) [values were two\\sided, and those <?005 were considered statistically significant. Analysis was performed using the Statistical Package for the Social Sciences (SPSS?, version 20; IBM Corp., Armonk, NY, USA). au, artificial models; B\\NHL, B\\cell non\\Hodgkin lymphoma; CI, confidence interval; CML, chronic myeloid leukaemia; ET, essential thrombocythemia; GMC, geometric mean concentration; IgG, immunoglobulin G; IMIDs, immunomodulatory imide drugs; MM, multiple myeloma; PI, proteasome inhibitor; PV, polycythaemia vera; SARS\\CoV\\2, severe acute respiratory syndrome coronavirus\\2; TI, time interval; TKIs, tyrosine kinase inhibitors; TP, time\\point; MF, myelofibrosis; @ hydroxycarbamide, ruxolitinib, interferon , anagrelide. #Anti SARS\\CoV\\2 S1\/S2 IgG determination was performed by the Liaison? SARS\\CoV\\2 S1\/S2 IgG assay (DiaSorin, Saluggia, Italy). 11 This is a quantitative chemiluminescent immunoassay (CLIA), fully automated around the LIAISON XL platform, for the detection of IgG antibodies against the subunits S1 and S2 of <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=gene&#038;cmd=Retrieve&#038;dopt=full_report&#038;list_uids=151888\">BTLA<\/a> SARS\\CoV\\2 Spike protein. The subunits S1 and S2 are responsible for binding and fusion of computer virus to host cell, respectively, and are both targets of neutralising antibodies. According to the manufacturers technical manual, the result of a Liaison SARS\\CoV\\2 S1\/S2 IgG test is usually positive with a signal of 15?au\/ml, equivocal between 12 and 15?au\/ml and unfavorable below 12?au\/ml. The cut\\off to discriminate positive and negative results was individuated on the basis of the 944% concordance between the Liaison IgG titre of 15?au\/ml and the Plaque Reduction Neutralisation Test 90% (PRNT90) SC-144 at 1:40 ratio. At a Liaison value of 80?au\/ml a concordance of 100% with a 1:160 PRNT90 titre was observed. 13 ##Angiotensin\\transforming enzyme 2 (ACE2)\\receptor\\binding domain name (RBD) Neutralising Assay (Dia.pro, Milan, Italy) 12 was used at TP3 to detect neutralising antibodies (NAbs) in an isotype\\indie manner using purified RBD and the host cell receptor ACE2. The test is usually a surrogate Computer virus Neutralising Test (sVNT), a method that mimics the virusChost conversation in an enzyme\\linked immunosorbent assay platewell. The RBD\\ACE2 conversation can be neutralised by specific NAbs in individual sera. The calculation of inhibition and the quantitative measurement of NAbs was performed according to the manufacturers instructions. The results are interpreted as a ratio of the cut\\off value (Co) and the sample OD450?nm\/620?nm (S). A Co\/S?>?10 indicates an efficient immunisation and vaccination effectiveness. 14 *No statistics were computed because responders were a constant. **Death from lymphoma progression. ^One of the 10 patients with MF was not tested by ACE2\\RBD Neutralising Assay because of sample unavailability. Open in a separate windows Fig 1 (A) Geometric mean concentrations (GMCs) of anti\\severe acute respiratory syndrome coronavirus\\2 (SARS\\CoV\\2) spike protein immunoglobulin G (IgG; au\/ml) according to seven different cohorts of haematological malignancy patients + control cohort at basal (TP0) and at 3 SC-144 (TP1), 5 (TP2) and 12 (TP3) weeks after BNT162b2 vaccination (first dose at TP0 and second at TP1). GMC values are reported as points at each TP. (B) Summary distribution of the anti\\SARS\\CoV\\2\\ spike protein IgG levels at TP3.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ufeffThe choice of the reference cut\\off appears fundamental to discriminate patients hypothetically protected by adequate levels of putatively neutralising antibodies. An asymptomatic SARS\\CoV\\2 infection was documented in two patients belonging to the third and seventh cohort when nasopharyngeal swabs were taken as surveillance before their hospital access on 9 July 2021. track the putatively neutralising &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-786","post","type-post","status-publish","format-standard","hentry","category-phosphatases","entry entry-center"],"_links":{"self":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts\/786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=786"}],"version-history":[{"count":1,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts\/786\/revisions"}],"predecessor-version":[{"id":787,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=\/wp\/v2\/posts\/786\/revisions\/787"}],"wp:attachment":[{"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cetaitdemain.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}